Chlamydia pneumonia (and other infective agents) in atherosclerosis and acute coronary syndromes. How good is the evidence?
Camm
A J
AJ
St Georges Hospital, London, UK.
Fox
K M
KM
D000208:Acute Disease; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000907:Antibodies, Bacterial / Q000032:analysis; D000942:Antigens, Bacterial / Q000032:analysis; D001161:Arteriosclerosis / Q000188:drug therapy / Q000382:microbiology*; D002690:Chlamydia Infections / Q000188:drug therapy / Q000382:microbiology*; D016993:Chlamydophila pneumoniae / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification*; D003327:Coronary Disease / Q000188:drug therapy / Q000382:microbiology*; D004269:DNA, Bacterial / Q000032:analysis; D004195:Disease Models, Animal; D006801:Humans
D000900:Anti-Bacterial Agents; D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D004269:DNA, Bacterial